Atlas Capital Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-60
| Closed | -$15.4K | – | 896 |
|
|
2023
Q3 | $15.4K | Sell |
60
-28
| -32% | -$7.2K | ﹤0.01% | 664 |
|
|
2023
Q2 | $25.1K | Hold |
88
| – | – | ﹤0.01% | 654 |
|
|
2023
Q1 | $24.5K | Sell |
88
-597
| -87% | -$166K | ﹤0.01% | 654 |
|
|
2022
Q4 | $190K | Buy |
+685
| New | +$190K | 0.03% | 349 |
|
|
2022
Q1 | – | Sell |
-143
| Closed | -$34.3K | – | 916 |
|
|
2021
Q4 | $34.3K | Sell |
143
-1,541
| -92% | -$370K | 0.01% | 579 |
|
|
2021
Q3 | $477K | Buy |
+1,684
| New | +$477K | 0.08% | 211 |
|
|
2021
Q1 | – | Sell |
-582
| Closed | -$143K | – | 795 |
|
|
2020
Q4 | $143K | Sell |
582
-1,868
| -76% | -$457K | 0.03% | 345 |
|
|
2020
Q3 | $695K | Sell |
2,450
-2,637
| -52% | -$748K | 0.16% | 134 |
|
|
2020
Q2 | $1.36M | Buy |
5,087
+4,957
| +3,813% | +$1.33M | 0.32% | 73 |
|
|
2020
Q1 | $41.1K | Buy |
+130
| New | +$41.1K | 0.01% | 460 |
|
|
2019
Q3 | – | Sell |
-810
| Closed | -$189K | – | 639 |
|
|
2019
Q2 | $189K | Sell |
810
-3,538
| -81% | -$827K | 0.06% | 300 |
|
|
2019
Q1 | $1.03M | Buy |
4,348
+4,311
| +11,651% | +$1.02M | 0.37% | 78 |
|
|
2018
Q4 | $11.1K | Hold |
37
| – | – | ﹤0.01% | 502 |
|
|
2018
Q3 | $13.1K | Hold |
37
| – | – | ﹤0.01% | 490 |
|
|
2018
Q2 | $13.1K | Sell |
37
-26
| -41% | -$9.23K | ﹤0.01% | 457 |
|
|
2018
Q1 | $17.3K | Buy |
+63
| New | +$17.3K | 0.01% | 457 |
|